bioRxiv Science⌕ Search

Biology subjects

Weinstock, L. D.

Publications and source records attributed to Weinstock, L. D..

5 recordsLinked to original sources

The phage stress test: a proving ground for genome language models in biological prediction

Reliable biological prediction by AI is most likely to emerge first in the simplest systems with rich datasets and the fastest opportunities for testing and refinement. Phages with small genomes are an ideal testbed. Decades of experimental work have created an unusually information-rich literature benchmark that sits largely outside the sequence repositories typically used to train genome language models (GLMs). Recent work has shown that GLMs such as Evo2 can generate viable whole bacteriophage genomes, demonstrating that genome-scale biological design is possible. The next question is more mechanistic: can such models correctly predict the effects of simple, local sequence changes? Here, we evaluated Evo2 against experimental mutation data from two model phages: the single-stranded RNA phage MS2 and the single-stranded DNA phage {Phi}X174. We first addressed whether Evo2 sequence log-likelihood scores could distinguish viable from nonviable mutations, and then whether models trained on Evo2 embeddings were predictive of function. Across both phages, Evo2 captured expected sequence-level constraints: stop codons were generally penalized, synonymous substitutions had higher likelihood than nonsynonymous substitutions. Evo2 distinguished among synonymous codons in ways only weakly explained by host codon usage. However, for MS2, these capabilities did not translate into robust biological predictions. Specifically, Evo2 {Delta}SLL failed to distinguish functional from nonfunctional mutations in the lysis gene, an overlapping viral region that appears to be a particularly hard test case. In {Phi}X174, performance was stronger but still modest, and much of the apparent signal could be explained by simple covariates such as nonsense mutations, genomic position, and nucleotide distance from the reference. Together, these results introduce phages as a tractable proving ground for stress-testing GLMs against experimentally grounded genotype-to-phenotype tasks. More broadly, they provide a durable framework for identifying what data and model ingredients are required for biologically reliable prediction.

bioinformatics↗

A reference genome without a virus: cDNA reconstruction reveals the provenance and function of the MS2 phage sequence

Reference genomes are often treated as faithful representations of experimentally validated viral genomes, yet the relationship between historically curated reference sequences and infectivity is rarely tested experimentally. Here, we developed a cDNA-based reconstruction platform for the canonical RNA phage MS2 and used it to compare the current NCBI reference genome (RefSeq) with closely related published isolate sequences. We found that isolate-derived sequences reproducibly yielded infectious phage, whereas the current MS2 RefSeq-derived construct did not, showing that the present reference does not represent a single experimentally validated infectious genome but instead reflects sequence curation across multiple studies. We then compared conventional and AI-enabled approaches to identify minimal changes that restore infectivity to MS2 RefSeq; a human experimentalist correctly prioritized corrective changes, whereas the genome language model Evo2 did not. We also observed that closely related corrected reference-derived constructs showed a ~4-log difference in phage output, and subsequent analysis indicated that this difference was associated with an apparent replicase frameshift in the lower-output background. This suggests that the low output construct class represents rare mutations from genomes that are one mutational step away from true function, rather than uniform function of the dominant construct population. A complementary cell-free assay provided a lower-background orthogonal readout of construct-level function, yielding ~1 x106 PFU/mL from the high-output background within 2 hours while showing no detectable recovery from the low-output background. Together, these results establish a robust platform for RNA phage reconstruction and raise the possibility that historical reference genomes, especially for RNA viruses, may not always remain faithful to experimentally validated biological function. More broadly, these findings underscore the need to verify the infectivity of reference genomes, particularly when they were assembled non-contiguously or shaped by cumulative human curation. They also highlight the importance of clearly distinguishing historically curated reference sequences from experimentally validated infectious genomes when such data are used to train or evaluate AI/ML models.

microbiology↗

Biomaterial encapsulation of human mesenchymal stromal cells modulates paracrine signaling response and enhances efficacy for treatment of established osteoarthritis

Mesenchymal stromal cells (MSCs) have shown promise as a treatment for osteoarthritis (OA); however, effective translation has been limited by numerous factors ranging from high variability and heterogeneity of hMSCs, to suboptimal delivery strategies, to poor understanding of critical quality and potency attributes. The objective of the current study was to assess the effects of biomaterial encapsulation in alginate microcapsules on human MSC (hMSC) secretion of immunomodulatory cytokines in an OA microenvironment and therapeutic efficacy in treating established OA. Lewis rats underwent Medial Meniscal Transection (MMT) surgery to induce OA. Three weeks post-surgery, after OA was established, rats received intra-articular injections of either encapsulated hMSCs or controls (saline, empty capsules, or non-encapsulated hMSCs). Six weeks post-surgery, microstructural changes in the knee joint were quantified using contrast enhanced microCT. Encapsulated hMSCs attenuated progression of OA including articular cartilage degeneration (swelling and cartilage loss) and subchondral bone remodeling (thickening and hardening). A multiplexed immunoassay panel (41 cytokines) was used to profile the in vitro secretome of encapsulated and non-encapsulated hMSCs in response to IL-1{square}, a key cytokine involved in OA. Non-encapsulated hMSCs showed an indiscriminate increase in all cytokines in response to IL-1{square} while encapsulated hMSCs showed a highly targeted secretory response with increased expression of some pro-inflammatory (IL-1{beta}, IL-6, IL-7, IL-8), anti-inflammatory (IL-1RA), and chemotactic (G-CSF, MDC, IP10) cytokines. These data show that biomaterial encapsulation using alginate microcapsules can modulate hMSC paracrine signaling in response to OA cytokines and enhance the therapeutic efficacy of the hMSCs in treating established OA.

bioengineering↗

Experimental control of macrophage pro-inflammatory dynamics using predictive models

Macrophage activity is a major component of the healthy response to infection and injury that consists of tightly regulated early pro-inflammatory activation followed by anti-inflammatory and regenerative activity. In numerous diseases, however, macrophage polarization becomes dysregulated and can not only impair recovery, but can also promote further injury and pathogenesis, e.g. after injury, in diabetes, or in Alzheimers disease. Dysregulated macrophages may either fail to polarize or become chronically polarized, resulting in increased production of cytotoxic factors, diminished capacity to clear pathogens, or failure to promote tissue regeneration. In these cases, a method of predicting and dynamically controlling macrophage polarization will enable a new strategy for treating diverse inflammatory diseases. In this work, we developed a model-predictive control framework to temporally regulate macrophage polarization. Using RAW 264.7 macrophages as a model system, we enabled temporal control by identifying transfer function models relating the polarization marker iNOS to exogenous pro- and anti-inflammatory stimuli. These stimuli-to-iNOS response models were identified using linear autoregressive with exogenous input terms (ARX) equations and were coupled with nonlinear elements to account for experimentally identified supra-additive and hysteretic effects. Using this model architecture, we were able to reproduce experimentally observed temporal iNOS dynamics induced with lipopolysaccharides (LPS) and interferon gamma (IFN-{gamma}). Moreover, the identified model enabled the design of time-varying input trajectories to experimentally sustain the duration and magnitude of iNOS expression. By designing transfer function models with the intent to predict cell behavior, we were able to predict and experimentally obtain temporal regulation of iNOS expression using LPS and IFN-{gamma} from both naive and non-naive initial states. Moreover, our data driven models revealed decaying magnitude of iNOS response to LPS stimulation over time that could be recovered using combined treatment with both LPS and IFN-{gamma}. Given the importance of dynamic tissue macrophage polarization and overall inflammatory regulation to a broad number of diseases, the temporal control methodology presented here will have numerous applications for regulating immune activity dynamics in chronic inflammatory diseases.

bioengineering↗

Microglial ERK activation is a critical regulator of pro-inflammatory immune responses in Alzheimer’s disease

BackgroundThe mitogen-activated protein kinase (MAPK) pathway is a central regulator of gene expression, pro-survival signaling, and inflammation. However, the importance of MAPK pathway signaling in regulating microglia-mediated neuroinflammation in Alzheimers Disease (AD) remains unclear. Here we examined the role of MAPK signaling in microglia using pre-clinical in-vitro and in-vivo models of AD pathology integrated with quantitative proteomics studies of post-mortem human brains.\n\nMethodsWe performed multiplexed immunoassay analyses of MAPK phosphoproteins, particularly ERK1/2, in acutely-isolated microglia and brain tissue from wild-type and 5xFAD mice. Neuropathological studies of mouse and human brain tissues were performed to quantify total and phosphorylated ERK protein in AD. The importance of ERK signaling in unstimulated and interferon {gamma} (IFN{gamma})-stimulated primary microglia cultures was investigated using NanoString transcriptomic profiling, coupled with functional assays of amyloid {beta} (A{beta}) and neuronal phagocytosis. Receptor tyrosine kinases (RTKs) likely responsible for ERK signaling in homeostatic microglia and disease-associated-microglia (DAM) states and ERK-regulated human AD risk genes were identified using gene expression data. Total and phosphorylated MAPKs in human post-mortem brain tissues were measured in quantitative proteomic datasets.\n\nResultsPhosphorylated ERK was the most strongly up-regulated signaling protein within the MAPK pathway in microglia acutely isolated from 5xFAD brains. Neuroinflammatory transcriptomic and phagocytic profiling of mouse microglia confirmed that ERK is a critical regulator of IFN{gamma}-mediated pro-inflammatory activation of microglia, although it was also important for constitutive microglial functions. Phospho-ERK was an upstream regulator of disease-associated microglia (DAM) gene expression (Trem2, Tyrobp), as well as of several human AD risk genes (Bin1, Cd33, Trem2, Cnn2). Among RTKs that signal via ERK, CSF1R and MERTK were primarily expressed by homeostatic microglia while AXL and FLT1 were likely regulators of ERK signaling in DAM. Within DAM, FLT4 and IGF1R were specifically expressed by pro- and anti-inflammatory DAM sub-profiles respectively. In quantitative proteomic analyses of post-mortem human brains from non-disease, asymptomatic and cognitively-impaired AD cases, ERK1 and ERK2 were the only MAPK pathway signaling proteins with increased protein expression and positive associations with neuropathological grade. Moreover, in a phospho-proteomic study of post-mortem human brains from controls, asymptomatic and symptomatic AD cases, we found evidence for a progressive increased flux through the ERK signaling pathway.\n\nConclusionsOur integrated analyses using pre-clinical models and human proteomic data strongly suggest that ERK phosphorylation in microglia is a critical regulator of pro-inflammatory immune response in AD pathogenesis and that modulation of ERK via upstream RTKs may reveal novel avenues for immunomodulation.

neuroscience↗